Antipsychotic and mood stabilizer efficacy and tolerability in pediatric and adult patients with bipolar I mania: a comparative analysis of acute, randomized, placebo-controlled trials.
about
Bipolar disorder in childrenDifferentiating bipolar disorder-not otherwise specified and severe mood dysregulationCanadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disordersIs bipolar always bipolar? Understanding the controversy on bipolar disorder in childrenPharmacotherapy of bipolar disorder in children and adolescents: an updateThe International College of Neuro-Psychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 2: Review, Grading of the Evidence, and a Precise AlgorithmThe Role of Topiramate in the Management of Cocaine Addiction: a Possible Therapeutic OptionTopiramate's effects on cocaine-induced subjective mood, craving and preference for money over drug taking.Predictive animal models of mania: hits, misses and future directions.Future directions for research on youth with bipolar spectrum disordersDatabase analysis of children and adolescents with bipolar disorder consuming a micronutrient formula.Treatment of Pediatric Bipolar Disorder: A ReviewMetabolic consequences of second-generation antipsychotics in youth: appropriate monitoring and clinical management.Bipolar disorder and disruptive mood dysregulation in children and adolescents: assessment, diagnosis and treatment.Some side effects and effcts on physical activity of second-generation antipsychotics: A study in children and adolescentsIntervention in the context of development: pathways toward new treatments.Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for PsychopharmacologyThe effects of carbamazepine on prefrontal activation in manic youth with bipolar disorder.Treatment of bipolar disorders during pregnancy: maternal and fetal safety and challenges.Child and adolescent psychiatrists' reported monitoring behaviors for second-generation antipsychoticsGlutamatergic effects of divalproex in adolescents with mania: a proton magnetic resonance spectroscopy study.Differing amygdala responses to facial expressions in children and adults with bipolar disorder.Effectiveness of a cognitive behavioral weight management intervention in obese patients with psychotic disorders compared to patients with nonpsychotic disorders or no psychiatric disorders: results from a 12-month, real-world study.Tolerability and Safety Profile of Cariprazine in Treating Psychotic Disorders, Bipolar Disorder and Major Depressive Disorder: A Systematic Review with Meta-Analysis of Randomized Controlled Trials.Treatment moderators and predictors of outcome in the Treatment of Early Age Mania (TEAM) studyMetabolic syndrome and adverse clinical outcomes in patients with bipolar disorder.Mood dysregulation.Frequency, characteristics and management of adolescent inpatient aggressionMood regulation in youth: research findings and clinical approaches to irritability and short-lived episodes of mania-like symptoms.Does sex moderate the clinical correlates of pediatric bipolar-I disorder? Results from a large controlled family-genetic study.Activating and Tranquilizing Effects of First-Time Treatment with Aripiprazole, Olanzapine, Quetiapine, and Risperidone in Youth.Child and adolescent psychiatrists' attitudes and practices prescribing second generation antipsychoticsClinical usefulness of second-generation antipsychotics in treating children and adolescents diagnosed with bipolar or schizophrenic disorders.Metabolic and cardiovascular adverse effects associated with antipsychotic drugs.Weight gain and increase of body mass index among children and adolescents treated with antipsychotics: a critical review.Practitioner review: Long-term pharmacological treatment of pediatric bipolar disorder.Do antipsychotics increase diabetes risk in children and adolescents?Weight gain and obesity in schizophrenia: epidemiology, pathobiology, and management.Is the perceived placebo effect comparable between adults and children? A meta-regression analysis.HPTLC Method for Estimation of Topiramate in Solubility Studies, Diffusion Studies, Plasma, Brain Homogenate and Pharmaceutical Formulation.
P2860
Q21284506-2ADF1FB1-2D1A-4CC4-AE92-6601E123C6EAQ22252416-B6A5A690-D1F8-4322-9829-27F0C8F863DCQ27009995-1B1C4CB6-327F-4ECF-93B9-7A35A124F3B5Q27011821-1A0B177A-8081-4D07-B647-CAED25A4A459Q27027052-FD1281A6-B19C-4874-9EB2-BC4C09E90CA9Q28066714-C1874701-4082-418F-A23D-4D4515A6923FQ28082830-3B99F230-B06E-4697-82B8-6A4C277F07ECQ30413247-FE3C3442-EAF7-412E-940E-43B66317D5AFQ30462823-24934C42-77D0-4F98-8741-7D1858844583Q34063460-301FA227-1C8E-435A-BAB2-ABC459D291FEQ34199313-79F9C1AF-0CBB-4098-969B-94F2F4C720EDQ34206467-6E4BADF8-D2C7-448F-AE48-50470F820A29Q34292768-1DF901DA-4FF2-41F2-8D2A-B4CC44FBD1CDQ34349662-7114F916-56DA-4363-841A-9CDBC7E95378Q34659629-CA1993EA-BA82-4C63-AEFE-F4413A8D15D5Q34675928-A6902F3D-CE82-4226-87E8-EE29E1A745DFQ34676317-B6FEF612-AFE8-4964-9256-C1147B8ACDF3Q34787700-50F1AD77-C52C-4115-92CF-17550CBE467CQ34823805-AB65B213-EFE7-4520-80EE-AD65754C2D99Q35641776-2588DCFA-138A-4FB6-8D77-85D4E04D8F51Q35843375-9A9C6F7A-181F-4445-948C-C860AC451E88Q36060183-8D1914C8-1888-47E2-9232-E328D37CE4ACQ36075717-074835A2-96F9-4AA0-BB4D-C90C8C236FB0Q36109823-A76CAE7D-9B52-42D1-85A8-410A715CDB30Q36188647-72CF46FD-C906-498E-A892-C944090D5483Q36225626-F759836A-2BF3-4A25-A62C-E6FC39470B6CQ36578095-7C7E805E-B278-45F5-B996-95E763AB119FQ36853104-B953530D-6E89-4F07-ADA7-CB87105953C8Q36864683-AB8A8104-62B5-46DF-9379-3EE69DA13E32Q36902078-4DC1DD3A-11AC-4ACB-8232-CA600BABE7C0Q37061277-FF430245-3BC2-4DAB-ABDB-B410A89E28B2Q37667623-F352CF53-9E24-45DC-8C53-47BEB65A0AA4Q37925811-7E72B208-37C5-4207-AE88-04863769D2C1Q37947095-3DD0FBAE-A0CB-4001-875B-07E7EC37DA7FQ38090490-60010201-302F-43F6-86A5-8F1D72BA5C8AQ38218213-B9BE0C51-58AE-42ED-8FD0-3A4D754DB435Q38283956-B633D654-E835-4381-820E-BEC52EAB2EA1Q38504254-77B74297-C723-48BA-B6A8-62897EEA766DQ38959593-4E5FB6F3-7E70-4913-96F6-B75A89E6D353Q39608917-CFC8B1E8-3B4D-4DDF-A30D-7C1F5CDED4E8
P2860
Antipsychotic and mood stabilizer efficacy and tolerability in pediatric and adult patients with bipolar I mania: a comparative analysis of acute, randomized, placebo-controlled trials.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Antipsychotic and mood stabili ...... ed, placebo-controlled trials.
@ast
Antipsychotic and mood stabili ...... ed, placebo-controlled trials.
@en
Antipsychotic and mood stabili ...... ed, placebo-controlled trials.
@nl
type
label
Antipsychotic and mood stabili ...... ed, placebo-controlled trials.
@ast
Antipsychotic and mood stabili ...... ed, placebo-controlled trials.
@en
Antipsychotic and mood stabili ...... ed, placebo-controlled trials.
@nl
prefLabel
Antipsychotic and mood stabili ...... ed, placebo-controlled trials.
@ast
Antipsychotic and mood stabili ...... ed, placebo-controlled trials.
@en
Antipsychotic and mood stabili ...... ed, placebo-controlled trials.
@nl
P2093
P2860
P1433
P1476
Antipsychotic and mood stabili ...... ed, placebo-controlled trials.
@en
P2093
Christoph U Correll
Eva M Sheridan
Melissa P DelBello
P2860
P304
P356
10.1111/J.1399-5618.2010.00798.X
P577
2010-03-01T00:00:00Z